H
H. de Kort
Researcher at Leiden University
Publications - 3
Citations - 640
H. de Kort is an academic researcher from Leiden University. The author has contributed to research in topics: Transplantation & Pancreas transplantation. The author has an hindex of 3, co-authored 3 publications receiving 528 citations. Previous affiliations of H. de Kort include Imperial College Healthcare.
Papers
More filters
Journal ArticleDOI
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
Alexandre Loupy,Mark Haas,Kim Solez,Lorraine C. Racusen,Denis Glotz,Daniel Serón,Brian J. Nankivell,Robert B. Colvin,Marjan Afrouzian,Enver Akalin,Nada Alachkar,Serena M. Bagnasco,Jan U. Becker,Lynn D. Cornell,Cinthia B. Drachenberg,Duska Dragun,H. de Kort,Ian W. Gibson,Edward S. Kraus,Carmen Lefaucheur,Ch. Legendre,Helen Liapis,Thangamani Muthukumar,Volker Nickeleit,Babak J. Orandi,Walter D. Park,Marion Rabant,Parmjeet Randhawa,Elaine F. Reed,Candice Roufosse,Surya V. Seshan,Banu Sis,Harsharan K. Singh,Carrie A. Schinstock,Anat R. Tambur,A. Zeevi,Michael Mengel +36 more
TL;DR: Improved definitions of TCMR and ABMR in pancreas transplants with specification of vascular lesions and prospects for defining a vascularized composite allograft rejection classification are included.
Journal ArticleDOI
Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients With De Novo Donor‐Specific Antibodies
H. de Kort,Michelle Willicombe,Paul Brookes,Kathy Dominy,Eva Santos-Nunez,Jack Galliford,Kakit Chan,David Taube,Adam McLean,H. T. Cook,Candice Roufosse +10 more
TL;DR: In renal transplant patients with de novo donor‐specific antibodies (dnDSA), microcirculation inflammation, defined by g’s and peritubular capillaritis scores, associates with graft survival in a retrospective cohort study.
Journal ArticleDOI
Diagnosis of Early Pancreas Graft Failure via Antibody‐Mediated Rejection: Single‐Center Experience With 256 Pancreas Transplantations
H. de Kort,M. J. K. Mallat,C. van Kooten,E. de Heer,S. H. Brand-Schaaf,A. M. van der Wal,Candice Roufosse,Dave L. Roelen,Jan A. Bruijn,Frans H.J. Claas,J. W. de Fijter,Ingeborg M. Bajema +11 more
TL;DR: In the setting of a thrombotic event, histopathological analysis of early pancreas graft loss is advisable to rule out the possibility of AMR, particularly because a diagnosis of acute AMR has important consequences for renal graft outcomes.